Dublin, April 20, 2026 (GLOBE NEWSWIRE)-- The "Viral Vector and Plasmid DNA Manufacturing Market (7th Edition): Industry Trends and Global Forecasts, till 2035" report has been added to ...
InVitria, a global leader in chemically defined, animal-origin-free recombinant proteins for advanced therapy manufacturing, announced its participation in the American Society of Gene and Cell ...
Peptide ligands can remove process- and product-related impurities from gene therapies better than protein ligands.
The SK pharmteco group is now offering a standardized viral vector and plasmid manufacturing process to a global audience. The global approach can help customers move to batches for clinical trials in ...
Switzerland's DINAMIQS receives Swissmedic approval for GMP viral vector production, becoming the country's first fully ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed and reproducibility, today announced the expansion of its ...
ViroCell Biologics has secured approval from the U.K.’s healthcare regulator to begin manufacturing and exporting the viral vector products it makes at a leading children's hospital. The London- and ...
Advances company’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leading GMP transfection reagents complement company’s upstream ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results